Literature DB >> 11305867

Production of MMPs in human cerebral endothelial cells and their role in shedding adhesion molecules.

V Hummel1, B A Kallmann, S Wagner, T Füller, A Bayas, J C Tonn, E N Benveniste, K V Toyka, P Rieckmann.   

Abstract

Matrix metalloproteinases (MMPs) are Zn2+-endopeptidases that seem to play an important role in chronic inflammatory diseases of the central nervous system by disrupting the blood-brain barrier (BBB) and mediating the destruction of myelin components. We therefore investigated the influence of the pro-inflammatory cytokine TNF-alpha. on the expression and activation of several MMPs in human cerebral endothelial cells (HCEC). HCEC constitutively express MMP-2 and MMP-3 mRNA, but only MMP-3 is upregulated on mRNA and protein level after TNF-alpha stimulation. MMP-9 and MMP-12 mRNA could only be detected under inflammatory conditions. Furthermore, MMPs are involved in shedding of cell surface molecules. We therefore investigated the influence of MMPs on the release of soluble adhesion molecules using marimastat, a specific broad-spectrum MMP inhibitor and other protease inhibitors like aprotinin or leupeptin. Only marimastat inhibited the TNF-alpha mediated release of sVCAM-1 in the supernatants of HCEC. Western blot results of culture supernatants supported the time dependent release of the complete extracellular portion of the VCAM-1 molecule. These data suggest that MMPs produced by HCEC are actively involved in the shedding of soluble adhesion molecules at the BBB.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11305867     DOI: 10.1093/jnen/60.4.320

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  16 in total

Review 1.  Biomarkers of AAA progression. Part 1: extracellular matrix degeneration.

Authors:  Femke A M V I Hellenthal; Willem A Buurman; Will K W H Wodzig; Geert Willem H Schurink
Journal:  Nat Rev Cardiol       Date:  2009-05-26       Impact factor: 32.419

Review 2.  Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.

Authors:  Kyle J Isaacson; M Martin Jensen; Nithya B Subrahmanyam; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2017-01-31       Impact factor: 9.776

3.  Proteolysis of the matricellular protein hevin by matrix metalloproteinase-3 produces a SPARC-like fragment (SLF) associated with neovasculature in a murine glioma model.

Authors:  Matt Weaver; Gail Workman; Chad R Schultz; Nancy Lemke; Sandra A Rempel; E Helene Sage
Journal:  J Cell Biochem       Date:  2011-11       Impact factor: 4.429

Review 4.  Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers.

Authors:  Ralf G Rempe; Anika M S Hartz; Björn Bauer
Journal:  J Cereb Blood Flow Metab       Date:  2016-06-20       Impact factor: 6.200

5.  Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction.

Authors:  Natthanej Luplertlop; Natthanej Luplerdlop; Dorothée Missé; Dorothy Bray; Virginie Deleuze; Jean-Paul Gonzalez; Vijittra Leardkamolkarn; Hans Yssel; Francisco Veas
Journal:  EMBO Rep       Date:  2006-10-06       Impact factor: 8.807

6.  Evaluation of soluble junctional adhesion molecule-A as a biomarker of human brain endothelial barrier breakdown.

Authors:  Axel Haarmann; Annika Deiss; Jürgen Prochaska; Christian Foerch; Babette Weksler; Ignacio Romero; Pierre-Olivier Couraud; Guido Stoll; Peter Rieckmann; Mathias Buttmann
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

7.  Influence of VEGF-R2 inhibition on MMP secretion and motility of microvascular human cerebral endothelial cells (HCEC).

Authors:  Sven Wagner; Tim Fueller; Vera Hummel; Peter Rieckmann; Joerg-Christian Tonn
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

8.  Reversal of West Nile virus-induced blood-brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor.

Authors:  Saguna Verma; Mukesh Kumar; Ulziijargal Gurjav; Stephanie Lum; Vivek R Nerurkar
Journal:  Virology       Date:  2009-11-18       Impact factor: 3.616

9.  Differential effects of Tat proteins derived from HIV-1 subtypes B and recombinant CRF02_AG on human brain microvascular endothelial cells: implications for blood-brain barrier dysfunction.

Authors:  Shawna M Woollard; Biju Bhargavan; Fang Yu; Georgette D Kanmogne
Journal:  J Cereb Blood Flow Metab       Date:  2014-03-26       Impact factor: 6.200

10.  Soluble vascular cell adhesion molecule (VCAM) is associated with treatment effects of interferon beta-1b in patients with secondary progressive multiple sclerosis.

Authors:  Peter Rieckmann; N Kruse; L Nagelkerken; K Beckmann; D Miller; C Polman; F Dahlke; K V Toyka; H P Hartung; S Stürzebecher
Journal:  J Neurol       Date:  2005-05       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.